Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma

Clinical trial NCT00024570 · COMPLETED

Trial details

NCT number: NCT00024570
Sponsor: INSYS Therapeutics Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Glioma Glioblastoma Multiforme Anaplastic Astrocytoma Mixed Oligoastrocytoma

Start date: 2000-11-01
Primary completion: 2007-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.